BenchSci Bridge · $28M raised · (2022)

BenchSci is building the world's first neuro-symbolic AI platform, ASCEND, to help scientists understand disease biology and accelerate drug discovery. ASCEND leverages a Biological Evidence Knowledge Graph (BEKG) and advanced AI to provide insights from diverse scientific data, including publications, multi-omics, and clinical trials. This platform aims to transform the drug discovery process by enabling R&D teams to go from hypothesis to successful experiment faster.